|
|
|
|
|
Detail |
| hsa-miR-29b |
|
Unspecified |
WITHDRAWN:MicroRNA profile in peripheral blood T cells of patients with primary biliary cirrhosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. |
2006 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
mir-29 regulates Mcl-1 protein expression and apoptosis. |
2007 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
MicroRNA 29b functions in acute myeloid leukemia |
2009 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Unspecified |
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. |
2008 |
|
|
|
|
|
|
| hsa-miR-29b |
|
Causal |
MicroRNA -29b induces global DNA hypomethylation and tumor suppressor gene re-expression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. |
2009 |
|
|
|
|
|
|